
|Articles|June 1, 2018
- Pharmaceutical Executive-06-01-2018
- Volume 38
- Issue 6
Pharmaceutical Executive, June 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
US Maps Strategy to Reform Drug Pricingalmost 8 years ago
C-Suite Personality: Fit for Future?almost 8 years ago
Insights for the Winalmost 8 years ago
Leveraging Lab Data in Advent of Personalized Marketingalmost 8 years ago
Asembia 2018: User-Friendly Urgencyalmost 8 years ago
Piecing Together the Pricing Puzzle: The Midterm Electionsabout 8 years ago
Pharm Exec's Top 50 Companies 2018Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5



